SYDNEY, NSW — The Australian Cancer Research Foundation (ACRF) has announced $7.5 million in cancer research funding today cutting-edge research technology and infrastructure to speed up discoveries in prevention, diagnosis and treatment of cancer.
Professor Ian Brown, CEO of Australian Cancer Research Foundation, emphasised the importance of the community’s support.
“Thanks to the generosity of our many supporters from around Australia we can award high-impact grants, allowing Australia’s best scientists to embark on revolutionary research projects. These cancer research initiatives investigate all types of cancer and act as a catalyst to speed up discoveries which ultimately working to save lives by saving time”.
“Every year ACRF encourages the Australian cancer research community to propose projects that are innovative and have great potential to make a significant impact on cancer prevention, detection and treatment. “Thirteen projects were submitted from across the country and assessed by ACRF’s eminent Medical Research Advisory Committee who were impressed by the quality and vision of the applications,” said Professor Brown.
The recipients of the annual ACRF grants in 2017 are:
• ACRF Centre for Imaging the Tumour Environment – $2 million for new imaging technology which will help develop new therapies by examining tumours within the patient’s body as well as individual cells in a tumour.
• ACRF Centre for Advanced Cancer Genomics – $1.75 million for equipment that will help build in-depth knowledge of all cell types that make up a tumour. This will provide new insights into how cancer cells evolve and interact with normal cells, leading to new treatments.
• ACRF Centre for Advanced Cellular Immunotherapy – $1.75 million for the development of manufacturing and monitoring facilities that will support new immunotherapy clinical trials.
• ACRF Oasis Research Centre – $2 million for a new facility that supports research into improving long-term health outcomes of cancer patients and survivors.
Since 1984, ACRF has awarded $136.8 million in grants to Australian cancer research institutes, hospitals and universities across the country to fund the technologies, infrastructure and equipment.
Funding from ACRF has helped get some of the most successful cancer research projects get off the ground, including the early support of the research that led to the cervical cancer vaccine.
ACRF is dedicated to funding research in Australia that has the power to make substantial breakthroughs in cancer prevention, diagnosis and treatment for all types of cancer across Australia.